HUM
41
-4
PGR
59
-3
CL
54
3
ADP
65
-3
GLW
45
-3
XYL
35
-2
GME
66
-5
ALLE
37
-4
MUR
44
-3
LEN
50
-2
ORCL
63
-4
XEL
67
2
ICE
59
-3
AN
50
-5
BDX
56
10
BBY
52
6
STX
45
-4
HAS
30
-2
JBHT
56
-3
CMA
61
-3
HUM
41
-4
PGR
59
-3
CL
54
3
ADP
65
-3
GLW
45
-3
XYL
35
-2
GME
66
-5
ALLE
37
-4
MUR
44
-3
LEN
50
-2
ORCL
63
-4
XEL
67
2
ICE
59
-3
AN
50
-5
BDX
56
10
BBY
52
6
STX
45
-4
HAS
30
-2
JBHT
56
-3
CMA
61
-3
Financhill
Back

Voyager Therapeutics Quote, Financials, Valuation and Earnings

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
Sell
34

VYGR
Voyager Therapeutics

Last Price:
5.65
Seasonality Move:
2.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Voyager Therapeutics Price Quote

$5.65
+0.01 (+-9.16%)
(Updated: November 16, 2024 at 5:44 AM ET)

Voyager Therapeutics Key Stats

Sell
34
Voyager Therapeutics (VYGR) is a Sell
Day range:
$5.59 - $6.15
52-week range:
$5.71 - $11.72
Dividend yield:
0%
P/E ratio:
2.09
P/S ratio:
2.26
P/B ratio:
1.01%
Volume:
794.8K
Avg. volume:
659K
1-year change:
-16.2%
Market cap:
$339.2M
Revenue:
$250M
EPS:
$0.22

How Much Does Voyager Therapeutics Make?

Is Voyager Therapeutics Growing As A Company?

  • What Is Voyager Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 5.09%
  • What Is Voyager Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Voyager Therapeutics Stock Price Performance

What Is Voyager Therapeutics 52-Week High & Low?

Voyager Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Voyager Therapeutics?

Is Voyager Therapeutics Cash Flow Positive?

  • What Is VYGR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.6M
  • What Is Voyager Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $114.2M
  • What Is Voyager Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$263.5M

Voyager Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VYGR return on invested capital is 3.5%
  • What Is Voyager Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 2.42%
  • What Is VYGR Return On Equity?
    ROE is a measure of profitability and is 3.5%

Voyager Therapeutics Earnings Date & Stock Price

Voyager Therapeutics Competitors

Voyager Therapeutics Dividend Yield

Voyager Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 60.49%
Revenue: 509.48% 110.46%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 17.33
Upside from Last Price: 207.33%

Major Shareholders

  • How many VYGR shares are owned by institutional investors?
    50.4M VYGR shares are owned by institutional investors
  • How many VYGR shares are owned by insiders?
    3M VYGR shares are owned by insiders